Default filter shows currently active projects. To see projects at other stages, use the status filters.
UK contribution to the 18th Replenishment of the World Bank International Development Association (IDA 18)
The United Kingdom's Contribution to the European Development Fund (EDF) for Aid under the Cotonou Agreement. This project was approved before the referendum on the UK’s membership of the EU. Work is now under way to understand the implications of leaving the EU for the UK’s development work
To provide the Department for International Development's (DFID) contribution to the European Union's activities in support of economic development and poverty reduction in Asia and Latin American countries and South Africa. The European Union activities contribute towards Member States pledges to commit 0.7% of Gross National Income (GNI) on Official Development Assistance (ODA)
UK contributions to compensate IDA the costs of foregone debt service payments under the Multilateral Debt Relief Initiative (MDRI)
Reduce vaccine preventable diseases (VPDs) in poor countries in a sustainable way using innovative financing approach
To tackle the immediate impact of the three most deadly infectious diseases – HIV/AIDS, tuberculosis and malaria – and put the international community on the right track to end the three diseases as epidemics by 2030.
Gavi supports vaccine delivery in 68 of the world's poorest countries reaching 60% of the world's birth cohort. Gavi immunises children against vaccine preventable diseases including measles, rubella, meningitis, cervical cancer, pneumonia and diarrhoea. Gavi has played a significant role in the recent halving of global child mortality. Over the 2016 to 2020, Gavi will fully deliver the UK target to immunise 76 million children and save 1.4 million lives. Gavi targets reaching those in hard to reach areas, the poorest, and the most marginalised. Gavi has a major global market shaping role for vaccines, negotiating lower prices for low-income countries, and incentivising new vaccines such as for Ebola and Malaria.
To support development and poverty reduction through environmental protection, and help developing countries respond to climate change
To scale up access to treatment for HIV/Aids, Malaria and Tuberculosis for poor people by funding programmes that (often through bulk international procurement) lower the price of quality drugs and diagnostics and accelerating the pace at which they are made available.
Increased responsible private sector participation in sustainable infrastructure in poorer developing countries through increased flows of private capital & expertise.This will benefit an additional 105.1 million people by the end of 2015.